odmj
OncoDaily Medical Journal
ODMJ
3067-6444
OncoDaily Medical Journal
US
6145
10.69690/ODMJ-001-1229-6145
Original Research
Setting up a Bone Marrow Transplant Unit in A Resource-Limited Country: Challenges and Learnings
Khan
Safia
Department of Bone marrow Transplant, Pakistan Kidney and Liver Institute and Research Center, Lahore, Pakistan
Safia.khan@pkli.org.pk
Hussain
Mussawair
Manchester University NHS Foundation Trust
Hussain
Fayyaza
Manchester University NHS Foundation Trust
29
12
2025
ODMJ-001-1229-6145
Copyright (c) 2025 OncoDaily Medical Journal
2025
OncoDaily Medical Journal
BMT
Bone Marrow Transplant
Hematology
ODMJ
Resource-Limited Country
Safia Khan
production-ready-file-url
[
Aljurf M, Weisdorf D, Hashmi SK, et al. Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic stem cell transplantation program in countries with limited resources (part II): clinical, technical and socio-economic considerations. Hematol Oncol Stem Cell Ther. 2020 Mar;13(1):7-16.
]
[
Ali N, Iftikhar R, Ayaz Mir M, et al. Haematopoietic stem cell transplant trends in Pakistan: activity survey from Pakistan Bone Marrow Transplant Group. J Transplant. 2023 Sep 28;2023:8865364.
]
[
Faulkner L. How to set up a successful transplant program for hemoglobinopathies in developing countries: the Cure2Children approach. Hematol Oncol Stem Cell Ther. 2020 Jun;13(2):71-5.
]
[
Dey BR, Yeh AC, Spitzer TR, et al. Establishing the first hematopoietic stem cell transplant unit in Nepal. Transplant Cell Ther. 2022 May;28(5):223-4.
]
[
Kanate AS, Majhail NS, Savani BN, et al. Indications for hematopoietic cell transplantation and immune effector cell therapy: guidelines from the American Society for Transplantation and Cellular Therapy. Biol Blood Marrow Transplant. 2020 Jul;26(7):1247-56.
]
[
Carreras E, Dufour C, Mohty M, et al., editors. The EBMT handbook: hematopoietic stem cell transplantation and cellular therapies [Internet]. 7th ed. Cham: Springer; 2019.
]
[
Mahar UR, Ahsan B, Ahmad U, et al. Developing an allogeneic hematopoietic progenitor cell transplant service in a resource-limited country: challenges and outcomes. Cureus. 2023 Sep 7;15(9):e44818.
]
[
World Health Organization. Cancer control: knowledge into action, WHO guide for effective programmes. Module 6: policy and advocacy [Internet]. Geneva: WHO Press; 2008. Available from: https://www.who.int/publications/i/item/cancer-control-policy-and-advocacy
]
[
Khan H, Ghafoor T, Shahbaz N, et al. Outcome of haematopoietic stem cell transplant in beta-thalassaemia major: single centre experience from a low- and middle-income country. J Coll Physicians Surg Pak. 2025 Apr;35(4):513-18.
]
[
Ayuk F, Balduzzi A, Worel N, et al. Donor selection for adults and pediatrics. In: Sureda A, Corbacioglu S, Greco R, et al., editors. The EBMT handbook: hematopoietic cell transplantation and cellular therapies [Internet]. 8th ed. Cham: Springer; 2024. Chapter 12.
]
[
Ifversen M, Meisel R, Sedlacek P, et al. Supportive care during pediatric hematopoietic stem cell transplantation: prevention of infections. A report from workshops on supportive care of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT). Front Pediatr. 2021 Jul 29;9:705179.
]
[
El Fakih R, Greinix H, Koh M, et al. Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations regarding essential medications required to establish an early stage hematopoietic cell transplantation program. Transplant Cell Ther. 2021 Mar;27(3):267.e1-5.
]
[
Nava T, Ansari M, Dalle JH, et al. Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 2020 Jun;55(6):1126-36.
]
[
Pasquini MC, Srivastava A, Ahmed SO, et al. Worldwide Network for Blood and Marrow Transplantation recommendations for establishing a hematopoietic cell transplantation program, part I: minimum requirements and beyond. Biol Blood Marrow Transplant. 2019 Dec;25(12):2322-9.
]
[
Cho SY, Lee HJ, Lee DG, et al. Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea. Korean J Intern Med. 2018 Mar;33(2):256-76.
]
[
Ullmann AJ, Schmidt-Hieber M, Bertz H, et al. Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016. Ann Hematol. 2016 Sep;95(9):1435-55.
]
[
Jaimovich G, Lazarus HM, Gale RP, et al. Hematopoietic cell transplants in resource-poor countries: challenges and opportunities. Expert Rev Hematol. 2023 Mar;16(3):163-9.
]
[
Passweg JR, Baldomero H, Chabannon C, et al. Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years. Bone Marrow Transplant. 2021 Jul;56(7):1651-64.
]
[
Angelucci E, Giannoni L. Current and future therapies for β-thalassaemia: a review article. EMJ Hematol. 2021;9(1):94-104.
]
[
Mikulska M, Gualandi F, Anserini P, et al. Early and late complications of hematopoietic stem cell transplantation. Handb Clin Neurol. 2024;202:135-51.
]